Theralase Technologies Inc. Retains Leading Investor Relations Firm

TORONTO, Sept. 12 /CNW/ - Theralase(TM) Technologies Inc. (TSX-V: TLT & OTC BB: TLTFF) (“Theralase”), a designer, manufacturer and distributor of therapeutic medical laser systems, announced today that it has retained The Equicom Group Inc. (“Equicom”) to provide the Company with strategic investor relations and financial communications services.

MORE ON THIS TOPIC